Implantation of the Aeson Total Artificial Heart — a device from Carmat designed to mimic the heart’s function —…
Articles by Lindsey Shapiro, PhD
Activation of an immune signaling molecule called STAT6 may lead to pulmonary hypertension (PH) in people with oxygen deprivation…
An artificial intelligence (AI)-based algorithm is capable of detecting features of pulmonary hypertension (PH) by analyzing heart sounds recorded…
A single dose of the investigational therapy TX45 improved heart function and blood flow, or hemodynamics, in people with…
Elevated blood levels of an inflammatory biomarker called the neutrophil-to-lymphocyte ratio (NLR) were associated with a higher risk of death…
Most adults with pulmonary arterial hypertension (PAH) who switched to Uptravi (selexipag) from other medications in its class…
Cereno Scientific‘s investigational therapy CS1 was well tolerated and showed signs of clinical benefit in people with pulmonary…
A global clinical trial evaluating a pulmonary artery denervation (PADN) device in people with pulmonary hypertension (PH) associated with…
An advisory committee of the European Medicines Agency (EMA) is recommending that Winrevair (sotatercept) be approved for the treatment…
Pulmonary arterial hypertension (PAH) patients enrolled in a Phase 2b clinical trial testing AV-101, an inhaled formulation of imatinib,…
AER-901, a new inhaled formulation of imatinib delivered via a specialized device, was predicted to reach 2-3 times higher levels…
Researchers have identified two inflammation-related genes — SELE and CCL20 — whose activity could serve as diagnostic biomarkers for the…